Pharmaceuticals News and Research

RSS

Chemo and radiation can kill more cancer cells and spare healthy ones, suggests Rutgers research

What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.

27 Feb 2014

Penn researchers identify possible new way to fight rare blood disorder

A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system - called "complement" -- that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.

27 Feb 2014

Valeant Pharmaceuticals total revenues up 109% in fourth quarter 2013

Valeant Pharmaceuticals International, Inc. announces fourth quarter financial results for 2013.

27 Feb 2014

Pacira Pharmaceuticals initiates Phase 3 clinical trial of EXPAREL in femoral nerve block

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that the Phase 3 clinical trial assessing the safety and efficacy of EXPAREL® (bupivacaine liposome injectable suspension) in femoral nerve block for total knee arthroplasty met its primary efficacy endpoint.

27 Feb 2014

Study raises concerns about use of acetaminophen during pregnancy

Acetaminophen, found in over-the-counter products such as Excedrin and Tylenol, provides many people with relief from headaches and sore muscles. When used appropriately, it is considered mostly harmless. Over recent decades, the drug, which has been marketed since the 1950s, has become the medication most commonly used by pregnant women for fevers and pain.

27 Feb 2014

Medicare official defends proposed changes to prescription drug program

In written testimony, Jonathan Blum, deputy administrator of the Centers For Medicare & Medicaid Services, says the changes are needed to head off cost increases, but an industry-sponsored study argues some of the changes could cost taxpayers more.

27 Feb 2014

Researchers discover new target for human antibodies that holds key to vaccine for dengue

Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for human antibodies that could hold the key to a vaccine for the world's most widespread mosquito-borne disease.

27 Feb 2014

ViroXis signs agreement with global pharmaceutical for marketing of OTC sandalwood oil-containing product

ViroXis Corporation is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of an over-the-counter (OTC) sandalwood oil-containing product.

26 Feb 2014

FDA approves KALYDECO for people with cystic fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.

26 Feb 2014

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals Inc., a joint venture with TFS Corporation Ltd., of Australia (ASX: TFC) is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of a number of over-the-counter (OTC) dermatology products containing TFS' sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO).

26 Feb 2014

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO).

26 Feb 2014

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

K-PAX Pharmaceuticals is working with Stanford University and several other leading research institutions to perform a Phase II double-blind, placebo-controlled trial to evaluate the safety and efficacy of a currently available FDA-approved medication concurrently administered with a novel mitochondrial support product in order to identify a safe and effective treatment for the chronic fatigue and decreased alertness (i.e. brain fog) that commonly afflicts people with CFS.

26 Feb 2014

Scales of zebrafish suitable for identifying new drugs for treating bone diseases

The scales of the zebrafish are very suitable for identifying potential new drugs for treating bone diseases. This is good news because it means fewer mice and rats will be needed for that work.

26 Feb 2014

Researchers develop new compound that slows down progression of Huntington's Disease

Juliet Ross is suffering from Huntington's Disease, a rare neurological disorder that affects one in 10.000 people. Due to a genetic defect, her body produces a toxic protein that damages neurons in her brain.

26 Feb 2014

Biothera’s Phase 2b clinical trial in NSCLC presented at International Association for the Study of Lung Cancer

Biothera presented results of its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) this past weekend to top clinicians and scientists at the invitation-only International Association for the Study of Lung Cancer meeting on targeted therapies in Santa Monica, CA.

26 Feb 2014

Agilent and CambTEK partner to co-market RES automated sample preparation technology

Agilent Technologies Inc. (NYSE:A) and CambTEK, Ltd. today announced an agreement to co-market CambTEK's Rapid Extraction System (RES) automated sample preparation technology with an assortment of Agilent's liquid phase separation, life science and chemical analysis instruments and software.

26 Feb 2014

Research grows "mini-livers" to reduce use of animals in science

Research that has for the first time successfully grown "mini-livers" from adult mouse stem cells has won the UK's international prize for the scientific and technological advance with the most potential to replace, reduce or refine the use of animals in science (the 3Rs).

26 Feb 2014

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).

25 Feb 2014

Infrared technique could help improve flow reactor chemistry for pharmaceuticals and other products

A pathway to more effective and efficient synthesis of pharmaceutical drugs and other flow reactor chemical products has been opened by a study in which for the first time the catalytic reactivity inside a microreactor was mapped in high resolution from start-to-finish.

25 Feb 2014

New report reveals prevalence of heroin-related overdose deaths in Kentucky

A new report from the Kentucky Injury Prevention and Research Center (KIPRC) reveals the prevalence and charges associated with drug overdose in the Bluegrass state.

25 Feb 2014

Pharmaceuticals News and Research

Chemo and radiation can kill more cancer cells and spare healthy ones, suggests Rutgers research

Penn researchers identify possible new way to fight rare blood disorder

Valeant Pharmaceuticals total revenues up 109% in fourth quarter 2013

Pacira Pharmaceuticals initiates Phase 3 clinical trial of EXPAREL in femoral nerve block

Study raises concerns about use of acetaminophen during pregnancy

Medicare official defends proposed changes to prescription drug program

Researchers discover new target for human antibodies that holds key to vaccine for dengue

ViroXis signs agreement with global pharmaceutical for marketing of OTC sandalwood oil-containing product

FDA approves KALYDECO for people with cystic fibrosis

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

Scales of zebrafish suitable for identifying new drugs for treating bone diseases

Researchers develop new compound that slows down progression of Huntington's Disease

Biothera’s Phase 2b clinical trial in NSCLC presented at International Association for the Study of Lung Cancer

Agilent and CambTEK partner to co-market RES automated sample preparation technology

Research grows "mini-livers" to reduce use of animals in science

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Infrared technique could help improve flow reactor chemistry for pharmaceuticals and other products

New report reveals prevalence of heroin-related overdose deaths in Kentucky

Event guide: 3rd EHS for Biopharma Summit eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence